Literature DB >> 864301

Relationship of systemic and intrarenal hemodynamics in cirrhosis.

M Epstein, N Schneider, B Befeler.   

Abstract

The relationship between systemic and renal hemodynamics was studied in 20 patients with advanced cirrhosis of the liver. Cardiac output was assessed by an indicator dilution technique, and both mean renal blood flow and intrarenal blood flow distribution were determined by the 133Xe washout method. Ten patients had elevated cardiac outputs (7.14 to 13.58 L/min; HCO group), seven patients had normal cardiac ouptputs (5.16 to 6.78; NCO group), and three had low cardiac outputs (3.65 to 4.1; LCO group). Renal hemodynamics did not correlate with cardiac output (r = 0.051; N.S.), since comparable reductions in mean renal blood flow occurred in both the LCO and HCO patients. Similarly, the degree of cortical ischemia, as assessed by percentage flow to the rapid flow component (C1%), did not correlate with cardiac output (r = 0.007; N.S.). Vasomotor instability as assessed by intrapatient variability of sequential xenon washout studies occurred frequently, and its magnitude did not correlate with cardiac output (r = -0.069; N.S.). These studies demonstrate that the abnormalities of intrarenal blood flow in cirrhosis are independent of alterations in cardiac output. Furthermore, the finding of marked intrarenal hemodynamic instability in the majority of patients with cirrhosis suggests that caution should be exercised in interpreting studies assessing the efficacy of vasoactive agents on renal hemodynamics in this disease, since the changes attributed to treatment may merely reflect spontaneous change.

Entities:  

Mesh:

Year:  1977        PMID: 864301

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

Review 1.  Interrelationship between renal haemodynamics, drug kinetics and drug action.

Authors:  K L Duchin; R W Schrier
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

2.  Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure.

Authors:  P Javlé; J Yates; H G Kynaston; K F Parsons; S A Jenkins
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

3.  [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].

Authors:  R Brunkhorst; E Wrenger; K Kühn; F W Schmidt; K Koch
Journal:  Klin Wochenschr       Date:  1989-08-01

Review 4.  Management of hepatorenal syndrome in patients with cirrhosis.

Authors:  Vicente Arroyo; Javier Fernández
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

5.  Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure.

Authors:  R Anand; D Harry; S Holt; P Milner; M Dashwood; D Goodier; M Jarmulowicz; K Moore
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 6.  New clues to the pathophysiology of hepatorenal failure.

Authors:  F Lang; W Gerok; D Häussinger
Journal:  Clin Investig       Date:  1993-02

7.  Pharmacokinetics of furosemide in patients with hepatic cirrhosis.

Authors:  G González; A Arancibia; M I Rivas; P Caro; C Antezana
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements.

Authors:  Ayse L Mindikoglu; Thomas C Dowling; Jade J Wong-You-Cheong; Robert H Christenson; Laurence S Magder; William R Hutson; Stephen L Seliger; Matthew R Weir
Journal:  Am J Nephrol       Date:  2014-06-17       Impact factor: 3.754

Review 9.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.